Evidence record 12351 · automatically gathered

Do AI-Native Biotechs Need Departments? Benchmarking Company World Models for AI-Driven Drug Development

AI-native biotechnology companies are often designed by copying human biotech org charts into agent roles. We argue for a different abstraction: a Company World Model, defined as a persistent asset-to-value state representation with transition models, explicit value functions, planning, and updating across scientific, regulatory, BD, commercial, financial, and execution constraints. We introduce a dry-lab benchmark for testing whether AI-agent organizations should mimic departments or operate ar

Record details

Published: 21 July 2026
Source: arXiv
Category: Research
Topics: Regulation · Healthcare · Agents & autonomy · Biotech
Retrieved: 22 July 2026

source-onlyevidence status

These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.

How to cite this record

ethics.ai (21 July 2026), “Do AI-Native Biotechs Need Departments? Benchmarking Company World Models for AI-Driven Drug Development,” evidence record 12351, https://ethics.ai/record/12351 (originally published by arXiv).

JSON

Use and limitations

This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.